株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血液透析・腹膜透析の世界市場 2021年までの予測:透析装置、ダイアライザー、AVフィステル針、AVグラフト、ブラッドライン、カテーテル、トランスファーセット、CAPD、APD

Hemodialysis and Peritoneal Dialysis Market by Products (Machines, Dialyzer, AV Fistula, AV Graft, Bloodlines, Catheters, Transfer Sets, CAPD, APD) & Services, Modality (Conventional, Nocturnal), End User - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 289914
出版日 ページ情報 英文 277 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.29円で換算しております。
Back to Top
血液透析・腹膜透析の世界市場 2021年までの予測:透析装置、ダイアライザー、AVフィステル針、AVグラフト、ブラッドライン、カテーテル、トランスファーセット、CAPD、APD Hemodialysis and Peritoneal Dialysis Market by Products (Machines, Dialyzer, AV Fistula, AV Graft, Bloodlines, Catheters, Transfer Sets, CAPD, APD) & Services, Modality (Conventional, Nocturnal), End User - Global Forecast to 2021
出版日: 2017年02月27日 ページ情報: 英文 277 Pages
概要

世界の人工透析市場は、2016〜2021年に6.0%のCAGR (複合年間成長率) で成長し、2021年には838億9000万米ドルの規模に達する、と推計されています。先進国市場では成熟化・成長率低下が進むものの、新興国市場では、末期腎疾患 (ESRD)・糖尿病・高血圧などの患者数の増加などに伴い、市場成長率が上昇すると見込まれています。他方、製品リコールの増加などが市場成長の妨げとなる可能性があります。市場の大半を血液透析が占める一方、腹膜透析も今後急速に成長する見通しです。

当レポートでは、世界の人工透析 (血液透析・腹膜透析) 製品・サービス市場について分析し、市場の基本構造や最新動向、主な市場促進・阻害要因、市場動向と今後の見通し (過去2年間・今後6年間分)、製品別・透析方式別・エンドユーザー別・地域別の詳細動向、市場競争・資本取引の状態、主要企業のプロファイルなどを調査・考察しております。

第1章 イントロダクション

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場のダイナミクス
    • 促進要因
      • 末期腎不全 (ESRD) 患者数の増加
      • 糖尿病・高血圧患者の増加
      • 高齢者人口の増大
      • 腎移植より透析処置を選択する患者の増加
      • 技術の進歩と新製品の上市
      • 新製品開発向け研究開発 (R&D) 支出の増額
      • ESRD治療費のための巨額の医療費支出
    • 抑制要因
      • 透析に関するリスク・合併症 (特に血管アクセスの場合)
      • 製品リコール
      • 医療費償還の問題 (新興国/先進国の場合)
      • 透析製品の認証・製造に対する厳格な規制・政策
    • 市場機会
      • 新興国市場
      • 使いやすく低コストな製品の開発
      • 透析センターの増加
      • 在宅血液透析治療の件数増加
    • 課題
      • 透析に対する腎移植の利点 (低コスト、高い患者生存率)
      • 競争の激しい市場における、中小企業の存続可能性

第6章 競争情報分析

  • ポーターのファイブフォース分析
  • 競争密度:透析製品市場 (Baxter、Fresenius、B. Braunの場合)
  • 透析製品・サービス市場:成長戦略の経験的評価
    • 戦略的な発展経路:有機的/無機的成長
    • 透析製品市場の場合
    • 透析サービス市場の場合

第7章 産業分析

  • イントロダクション
  • 産業動向
    • ウェアラブル/小型透析装置への注目
    • 透析サービス市場の再編
    • 透析製品/サービス企業どうしの提携
    • プライベートエクイティ取引の持続的な活況
    • 民間の透析サービス業者の人気拡大
  • 医療費償還のシナリオ (地域別)
  • 規制環境 (地域別)

第8章 透析の処置件数:方式別

  • イントロダクション
  • 血液透析 (HD) の処置件数
  • 腹膜透析 (PD) の処置件数
  • 血液透析 vs. 腹膜透析

第9章 世界の血液透析市場

  • 製品別・サービス別分析
    • イントロダクション
    • 血液透析製品
      • 血液透析装置 (施設用/在宅用)
      • 血液透析用消耗品・備品
        • ダイアライザー (透析器):素材別、流量別
        • アクセス用製品 (静動脈 (AV) フィステル針、AVグラフト、中央静脈カテーテル (CVC))
        • ブラッドライン
        • 血液透析用濃縮物/透析液 (アルカリ性、酸性)
        • その他
    • 血液透析サービス市場
      • 施設内血液透析サービス
      • 在宅血液透析サービス
  • 透析方式別の分析
    • 従来型・長期間の血液透析
    • 短時間・日常的な血液透析
    • 夜間血液透析
  • 水処理装置市場:種類別
    • 集中型水殺菌装置市場
      • 化学式殺菌装置市場
      • 熱式殺菌装置
      • 付属品
    • 可搬式水殺菌装置市場

第10章 世界の腹膜透析市場

  • 製品別・サービス別分析
    • イントロダクション
    • 腹膜透析製品
      • 腹膜透析用濃縮物/透析液
      • 腹膜透析装置
      • 腹膜透析用カテーテル
      • 腹膜透析トランスファーセット
      • その他
    • 腹膜透析サービス
  • 方式別の分析
    • CAPD (連続携行式腹膜透析)
    • APD (自動腹膜透析)

第11章 世界の透析市場:エンドユーザー別

  • イントロダクション
  • 施設内透析 (病院、独立系透析センター)
  • 在宅透析 (腹膜透析、血液透析)

第12章 世界の透析市場:地域別

  • イントロダクション
    • 北米 (米国、カナダ)
  • 欧州 (ドイツ、フランス、英国など)
  • アジア太平洋地域 (日本、中国、インドなど)
  • その他の地域 (ラテンアメリカ、中東、アフリカ)

第13章 競争環境

  • 概要
  • 市場シェア分析:主要企業別
    • 透析製品市場の主要企業
    • 血液透析製品市場の主要企業
    • 透析サービス市場の主要企業
    • 血液透析サービス市場の主要企業
    • 腹膜透析市場の主要企業
  • 競争状況と動向
    • 事業拡張
    • 企業合併・買収 (M&A)
    • 契約・事業提携
    • 新製品の上市・認証
    • その他の戦略

第14章 企業プロファイル

  • イントロダクション
  • FRESENIUS MEDICAL CARE AG & CO. KGAA
  • DAVITA HEALTHCARE PARTNERS INC.
  • BAXTER INTERNATIONAL INC.
  • B. BRAUN MELSUNGEN AG
  • DIAVERUM DEUTSCHLAND GMBH
  • ニプロ
  • NXSTAGE MEDICAL, INC.
  • 日機装
  • MAR COR PURIFICATION, INC. (A CANTEL MEDICAL COMPANY)
  • 旭化成メディカル (旭化成の子会社)

第15章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 2157

The global hemodialysis and peritoneal dialysis market is estimated to reach 83.89 billion by 2021, at a CAGR of 6.0% from 2016 to 2021. Although the global hemodialysis and peritoneal dialysis market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness a high growth rate in emerging countries such as China, India, and Brazil. The growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension (major causes of kidney failure), rapid growth in the aging population, preference for dialysis treatments over kidney transplants due to lack of donors, and initiatives taken by leading players to introduce advanced products & services. However, a number of product recalls and the risks & complications associated with dialysis are restricting the growth of this market to a certain extent.

The global hemodialysis and peritoneal dialysis market is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis. The hemodialysis (HD) products and services market include machines, consumables, and services. The peritoneal dialysis (PD) products and services market include machines, concentrates/dialysates, catheters, transfer sets, and PD services. Furthermore, on the basis of end user, the global hemodialysis and peritoneal dialysis market has been segmented into in-center dialysis and home dialysis.

In 2016, the hemodialysis segment is expected to account for largest share of the market. Factors such as the huge acceptance of hemodialysis therapy over peritoneal dialysis among CKD and ESRD patients, increasing number of ESRD patients, growth in the number of dialysis centers, and government initiatives are stimulating the growth of the hemodialysis market. However, the peritoneal dialysis market is estimated to grow at the highest CAGR during the forecast period.

Geographically, North America is expected to command the largest share of the global hemodialysis and peritoneal dialysis market in 2016, followed by Europe. A number of factors such as the growing dialysis patient pool and increasing prevalence of diabetes and hypertension are propelling the growth of the North American dialysis market. Additionally, factors such as the growing inclination towards peritoneal dialysis and the rising adoption of home hemodialysis/nocturnal dialysis are also contributing to the growth of this market. According to the U.S. Renal Data System, the number of peritoneal dialysis patients opting for self-treatment at home rose by 24% from 2008 to 2011.

The Asia-Pacific region is poised to grow at the highest CAGR in the next five years. Factors such as the presence of a large patient population base, increasing number of private and public owned dialysis centers, improving reimbursement and insurance scenario, rising focus of global players, and increasing government initiatives are propelling the growth of the dialysis market in the Asia-Pacific region.

The global hemodialysis and peritoneal dialysis market is highly competitive, with a large number of players (including dialysis products market players and dialysis services market players). As of 2015, the global dialysis products market was dominated by Fresenius Medical Care AG & Co. KGaA (Germany) and Baxter International, Inc. (U.S.); whereas in the global hemodialysis and peritoneal dialysis services market, Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), and Diaverum Deutschland GmbH (Germany) were the top three market players. Partnerships/agreements/collaborations/joint ventures, and acquisitions are the major strategies adopted by most of the market players to achieve growth in the hemodialysis and peritoneal dialysis market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis - industry analysis (porter's five force model), market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high growth segments of the hemodialysis and peritoneal dialysis market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities. The above mentioned market research data, current market size, and forecast of future trends will help existing players and new entrants to make the necessary decisions regarding the product offerings, geographic focus, change in strategic approach, R&D investment for innovation in products and technologies, and levels of output in order to remain successful.

Firms purchasing the report could use any one or combination of the below mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping market share.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on dialysis products and services offered by the top 10 players in the global hemodialysis and peritoneal dialysis market. The report analyzes the market by product & service, modality, end user, and region
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various dialysis products and services across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global hemodialysis and peritoneal dialysis market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and recent developments of the leading players in the global hemodialysis and peritoneal dialysis market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key industry insights
        • 2.2.2.2.1. Supply side
        • 2.2.2.2.2. Demand side
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.3.1. ESTIMATION OF DIALYSIS PROCEDURAL VOLUME
    • 2.3.2. RESEARCH METHODOLOGY: TOP-DOWN APPROACH {FOR MARKET SIZE ESTIMATION OF HD AND PD DISPOSABLES (BLOODLINE SETS, DIALYZERS, CATHETERS, TRANSFER SETS, AND CONCENTRATES/DIALYSATES)}
    • 2.3.3. RESEARCH METHODOLOGY: TOP-DOWN APPROACH (FOR MARKET-SIZE ESTIMATION OF HD/PD MACHINES)
    • 2.3.4. RESEARCH METHODOLOGY: BOTTOM-UP APPROACH (FOR HD AND PD DIALYSIS PRODUCTS MARKET)
    • 2.3.5. RESEARCH METHODOLOGY: BOTTOM-UP APPROACH (FOR HD AND PD DIALYSIS SERVICES MARKET)
  • 2.4. RESEARCH DESIGN
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. HEMODIALYSIS & PERITONEAL DIALYSIS MARKET OVERVIEW
  • 4.2. GEOGRAPHICAL SNAPSHOT OF HEMODIALYSIS & PERITONEAL DIALYSIS MARKET
  • 4.3. GLOBAL HEMODIALYSIS MARKET, BY PRODUCTS & SERVICES (2016 VS. 2021)
  • 4.4. HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, BY END-USER, 2016 VS. 2021(USD BILLION)
  • 4.5. HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, BY TYPE, 2016 VS. 2021
  • 4.6. GLOBAL PERITONEAL DIALYSIS MARKET, BY PRODUCTS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing number of ESRD patients
      • 5.2.1.2. Growing prevalence of diabetes and hypertension
      • 5.2.1.3. Rapid growth in the aging population
      • 5.2.1.4. Preference for dialysis procedures over renal transplants
      • 5.2.1.5. Technological advancements and new product launches
      • 5.2.1.6. Rising R&D expenditure for the development of new dialysis products
      • 5.2.1.7. Substantial healthcare expenditure on the treatment of ESRD
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Risks and complications associated with dialysis
        • 5.2.2.1.1. High risk and complications related to vascular access
      • 5.2.2.2. Product recalls
      • 5.2.2.3. Reimbursements Concerns
        • 5.2.2.3.1. Emerging Markets
        • 5.2.2.3.2. Mature Markets
      • 5.2.2.4. Stringent regulatory policies for approval and manufacturing of dialysis products
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
      • 5.2.3.2. Development of user-friendly and low-cost dialysis products
      • 5.2.3.3. Increasing number of dialysis centers
      • 5.2.3.4. Growing adoption of home hemodialysis treatment
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Benefits of renal transplantation versus dialysis
        • 5.2.4.1.1. Low cost solution
        • 5.2.4.1.2. Better patient survival rate
      • 5.2.4.2. Sustainability of small and mid-sized companies in the highly competitive market

6. COMPETITIVE INTELLIGENCE

  • 6.1. PORTER'S FIVE FORCES ANALYSIS
    • 6.1.1. SEGMENT RIVALRY
    • 6.1.2. THREAT OF SUBSTITUTES
    • 6.1.3. THREAT OF NEW ENTRANTS
    • 6.1.4. SUPPLIER'S BARGAINING POWER
    • 6.1.5. BUYER'S BARGAINING POWER
  • 6.2. COMPETITIVE INTENSITY: DIALYSIS PRODUCTS MARKET
    • 6.2.1. EVALUATION PARAMETERS AND SCORES
    • 6.2.2. SCORING METHODOLOGY
    • 6.2.3. COMPETITIVE INTENSITY SCORE, BY COMPANY
      • 6.2.3.1. Fresenius medical care AG & Co. KGaA
      • 6.2.3.2. Baxter International, Inc.
      • 6.2.3.3. B. Braun melsungen AG
    • 6.2.4. COMPETITIVE INTENSITY - MAPPING OF BAXTER, B.BRAUN, AND FRESENIUS
  • 6.3. DIALYSIS PRODUCTS AND SERVICES MARKET: EMPIRICAL ASSESSMENT OF GROWTH STRATEGIES
      • 6.3.1.1. Path towards strategic development - organic and inorganic growth strategies
      • 6.3.1.2. Dialysis products market
        • 6.3.1.2.1. Organic Growth Strategies
        • 6.3.1.2.2. Inorganic Growth Strategies
      • 6.3.1.3. Dialysis services market
        • 6.3.1.3.1. Organic Growth Strategies
        • 6.3.1.3.2. Inorganic Growth Strategies

7. INDUSTRY INSIGHTS

  • 7.1. INTRODUCTION
  • 7.2. INDUSTRY TRENDS
    • 7.2.1. FOCUS ON WEARABLE AND MINIATURE DIALYSIS MACHINES
    • 7.2.2. CONSOLIDATION OF THE DIALYSIS SERVICES MARKET
    • 7.2.3. PARTNERSHIPS AMONG DIALYSIS PRODUCT AND SERVICE PROVIDERS
    • 7.2.4. CONTINUING ROBUST PRIVATE EQUITY ACTIVITY
    • 7.2.5. INCREASING PREFERENCE FOR PRIVATE DIALYSIS PROVIDERS
  • 7.3. REIMBURSEMENT SCENARIO
    • 7.3.1. NORTH AMERICA
    • 7.3.2. EUROPE
      • 7.3.2.1. Germany
      • 7.3.2.2. France
      • 7.3.2.3. Belgium
      • 7.3.2.4. U.K.
      • 7.3.2.5. Netherlands
    • 7.3.3. ASIA-PACIFIC
      • 7.3.3.1. Asian Region (Except Japan)
      • 7.3.3.2. Japan
      • 7.3.3.3. Pacific region
    • 7.3.4. REST OF THE WORLD
      • 7.3.4.1. Latin America
      • 7.3.4.2. Africa
  • 7.4. REGULATORY LANDSCAPE
    • 7.4.1. NORTH AMERICA
      • 7.4.1.1. U.S.
      • 7.4.1.2. Canada
    • 7.4.2. EUROPE
    • 7.4.3. ASIA-PACIFIC
      • 7.4.3.1. India
      • 7.4.3.2. China
      • 7.4.3.3. Japan
      • 7.4.3.4. South Korea
    • 7.4.4. REST OF THE WORLD
      • 7.4.4.1. Latin America
        • 7.4.4.1.1. Brazil
        • 7.4.4.1.2. Argentina
        • 7.4.4.1.3. Mexico
      • 7.4.4.2. Middle East
      • 7.4.4.3. Africa

8. ADOPTION OF DIALYSIS MODALITIES

  • 8.1. INTRODUCTION
  • 8.2. HEMODIALYSIS (HD) PROCEDURES
  • 8.3. PERITONEAL DIALYSIS (PD) PROCEDURES
  • 8.4. HD VS. PD

9. GLOBAL HEMODIALYSIS MARKET

  • 9.1. HEMODIALYSIS MARKET, BY PRODUCTS & SERVICES
    • 9.1.1. INTRODUCTION
    • 9.1.2. HEMODIALYSIS PRODUCTS
      • 9.1.2.1. Hemodialysis Machines
        • 9.1.2.1.1. Center-use Hemodialysis Machines
        • 9.1.2.1.2. Home-use Hemodialysis Machines
      • 9.1.2.2. Hemodialysis Consumables/Supplies
        • 9.1.2.2.1. Dialyzers
        • 9.1.2.2.2. Dialyzers market, by material type
        • 9.1.2.2.2.1. Synthetic dialyzers
        • 9.1.2.2.2.2. Cellulose-based dialyzers
        • 9.1.2.2.3. Dialyzers market, by flux type
        • 9.1.2.2.3.1. High-flux Dialyzers
        • 9.1.2.2.3.2. Low-flux Dialyzers
        • 9.1.2.2.4. Hemodialysis Access Products
        • 9.1.2.2.4.1. Arteriovenous (AV) Fistula
        • 9.1.2.2.4.2. Arteriovenous Grafts
        • 9.1.2.2.4.3. Central Venous Catheters
        • 9.1.2.2.5. Bloodlines
        • 9.1.2.2.6. Hemodialysis Concentrates/Dialysates
        • 9.1.2.2.6.1. Alkaline Concentrates
        • 9.1.2.2.6.2. Acidic Concentrates
        • 9.1.2.2.7. Other hemodialysis consumables
    • 9.1.3. HEMODIALYSIS SERVICES
      • 9.1.3.1. In-center hemodialysis services
      • 9.1.3.2. Home hemodialysis services
  • 9.2. HEMODIALYSIS MARKET, BY MODALITY
    • 9.2.1. CONVENTIONAL LONG-TERM HEMODIALYSIS
    • 9.2.2. SHORT DAILY HEMODIALYSIS
    • 9.2.3. NOCTURNAL HEMODIALYSIS
  • 9.3. WATER TREATMENT SYSTEMS MARKET, BY TYPE
    • 9.3.1. CENTRAL WATER DISINFECTION SYSTEMS MARKET
      • 9.3.1.1. Chemical Disinfection Systems Market
      • 9.3.1.2. Heat Disinfection Systems
      • 9.3.1.3. Accessories
    • 9.3.2. PORTABLE WATER DISINFECTION SYSTEMS MARKET
      • 9.3.2.1. Chemical Disinfection Systems
      • 9.3.2.2. Heat Disinfection Systems
      • 9.3.2.3. Accessories

10. GLOBAL PERITONEAL DIALYSIS MARKET

  • 10.1. PERITONEAL DIALYSIS MARKET, BY PRODUCT AND SERVICE
    • 10.1.1. INTRODUCTION
    • 10.1.2. PRODUCTS
      • 10.1.2.1. Peritoneal dialysis concentrates/dialysates
      • 10.1.2.2. Peritoneal dialysis machines
      • 10.1.2.3. Peritoneal dialysis catheters
      • 10.1.2.4. Peritoneal dialysis transfer sets
      • 10.1.2.5. Other peritoneal dialysis products
    • 10.1.3. PERITONEAL DIALYSIS SERVICES
  • 10.2. PERITONEAL DIALYSIS MARKET, BY MODALITY
    • 10.2.1. CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD)
    • 10.2.2. AUTOMATED PERITONEAL DIALYSIS (APD)

11. GLOBAL DIALYSIS MARKET, BY END USER

  • 11.1. INTRODUCTION
  • 11.2. IN-CENTER DIALYSIS
    • 11.2.1. HOSPITAL DIALYSIS
    • 11.2.2. INDEPENDENT DIALYSIS CENTERS
  • 11.3. HOME DIALYSIS
    • 11.3.1. PERITONEAL DIALYSIS
    • 11.3.2. HOME HEMODIALYSIS
      • 11.3.2.1. High cost of dialysis treatment

12. GLOBAL DIALYSIS MARKET, BY REGION

  • 12.1. INTRODUCTION
  • 12.2. NORTH AMERICA
      • 12.2.1.1. Consolidation of markets in North America
    • 12.2.2. U.S.
        • 12.2.2.1.1. Bundle reimbursement, a strong incentive for dialysis providers to encourage PD adoption
        • 12.2.2.1.2. Underutilization of home HD in the U.S.
      • 12.2.2.2. Canada
        • 12.2.2.2.1. High government expenditure for not-for-profit hospitals to deliver dialysis care
        • 12.2.2.2.2. Rising focus of provincial hospitals on providing quality care
  • 12.3. EUROPE
      • 12.3.1.1. Germany
      • 12.3.1.2. France
        • 12.3.1.2.1. Improvement in reimbursement scenario for dialysis in France
      • 12.3.1.3. U.K.
        • 12.3.1.3.1. The U.K., an attractive market for small dialysis players
        • 12.3.1.3.2. Low utilization of home dialysis in the U.K.
      • 12.3.1.4. Rest of Europe
        • 12.3.1.4.1. Huge growth potential in Eastern Europe
        • 12.3.1.4.2. Spain: Focus of market players, favorable reimbursement scenario
        • 12.3.1.4.3. Italy: Growing medical tourism and presence of infrastructure
  • 12.4. ASIA-PACIFIC
      • 12.4.1.1. Increasing focus of dialysis firms on Asia-Pacific
      • 12.4.1.2. High cost of treatment and poor reimbursement scenario
      • 12.4.1.3. Japan
        • 12.4.1.3.1. Low preference for kidney transplantation
        • 12.4.1.3.2. High entry barriers in Japan for foreign players
      • 12.4.1.4. China
        • 12.4.1.4.1. China halts anti-dumping probe into foreign dialysis kit makers
      • 12.4.1.5. India
        • 12.4.1.5.1. Evolving home dialysis treatment in the country
        • 12.4.1.5.2. Poor accessibility of dialysis treatment
        • 12.4.1.5.3. Dearth of indigenous manufacturers for dialysis machines and dialyzers in India
      • 12.4.1.6. Rest of Asia-Pacific (RoAPAC)
        • 12.4.1.6.1. South Korean hemodialysis and peritoneal dialysis market growing at a high rate
        • 12.4.1.6.2. Underutilization of home dialysis in Australia
        • 12.4.1.6.3. High ESRD prevalence and rising government focus driving the growth of the Taiwanese dialysis market
        • 12.4.1.6.4. Singapore: Growing research and increasing number of patients
        • 12.4.1.6.5. Effective promotion of PD in Hong Kong
  • 12.5. REST OF THE WORLD
      • 12.5.1.1. Latin America
        • 12.5.1.1.1. High usage of PD in the Latin America
        • 12.5.1.1.2. New amendments open Brazilian dialysis industry to foreign investment
        • 12.5.1.1.3. Mexico shows the highest utilization of PD in the world
      • 12.5.1.2. Middle East
      • 12.5.1.3. Africa

13. COMPETITIVE LANDSCAPE

  • 13.1. OVERVIEW
  • 13.2. MARKET SHARE ANALYSIS, BY KEY PLAYER
    • 13.2.1. KEY PLAYERS IN THE DIALYSIS PRODUCTS MARKET
    • 13.2.2. KEY PLAYERS IN THE HEMODIALYSIS PRODUCTS MARKET
    • 13.2.3. KEY PLAYERS IN THE DIALYSIS SERVICES MARKET
    • 13.2.4. KEY PLAYERS IN THE HEMODIALYSIS SERVICES MARKET
    • 13.2.5. KEY PLAYERS IN THE PERITONEAL DIALYSIS PRODUCTS MARKET
  • 13.3. COMPETITIVE SITUATION AND TRENDS
    • 13.3.1. EXPANSIONS
    • 13.3.2. MERGERS & ACQUISITIONS
    • 13.3.3. AGREEMENTS & PARTNERSHIPS
    • 13.3.4. PRODUCT LAUNCHES AND APPROVALS
    • 13.3.5. OTHER STRATEGIES

14. COMPANY PROFILES (Overview, Financial*, Products & Services, Strategy, and Developments)

  • 14.1. INTRODUCTION
  • 14.2. FRESENIUS MEDICAL CARE AG & CO. KGAA
  • 14.3. DAVITA HEALTHCARE PARTNERS INC.
  • 14.4. BAXTER INTERNATIONAL INC.
  • 14.5. B. BRAUN MELSUNGEN AG
  • 14.6. DIAVERUM DEUTSCHLAND GMBH
  • 14.7. NIPRO CORPORATION
  • 14.8. NXSTAGE MEDICAL, INC.
  • 14.9. NIKKISO CO., LTD.
  • 14.10. MAR COR PURIFICATION, INC. (A CANTEL MEDICAL COMPANY)
  • 14.11. ASAHI KASEI MEDICAL CO., LTD. (A SUBSIDIARY OF ASAHI KASEI CORPORATION)

*Details might not be captured in case of unlisted companies.

15. APPENDIX

  • 15.1. DISCUSSION GUIDE
  • 15.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 15.4. AVAILABLE CUSTOMIZATIONS
  • 15.5. RELATED REPORTS
  • 15.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: PROMINENT ACQUISITIONS IN THE DIALYSIS SERVICES INDUSTRY (2013-2016)
  • TABLE 2: GLOBAL HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD BILLION)
  • TABLE 3: GLOBAL HEMODIALYSIS PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 4: GLOBAL HEMODIALYSIS PRODUCTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 5: GLOBAL HEMODIALYSIS MACHINES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 6: GLOBAL HEMODIALYSIS MACHINES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 7: CENTER-USE HEMODIALYSIS MACHINES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 8: GLOBAL HOME-USE HEMODIALYSIS MACHINES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 9: GLOBAL HEMODIALYSIS CONSUMABLES/SUPPLIES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 10: GLOBAL HEMODIALYSIS CONSUMABLES/SUPPLIES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 11: GLOBAL DIALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 12: GLOBAL DIALYZERS MARKET SIZE, BY MATERIAL TYPE, 2014-2021 (USD BILLION)
  • TABLE 13: GLOBAL SYNTHETIC DIALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 14: GLOBAL CELLULOSE-BASED DIALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 15: GLOBAL DIALYZERS MARKET SIZE, BY FLUX TYPE, 2014-2021 (USD BILLION)
  • TABLE 16: HIGH-FLUX DIALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 17: GLOBAL LOW-FLUX DIALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 18: GLOBAL HEMODIALYSIS ACCESS PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 19: GLOBAL HEMODIALYSIS ACCESS PRODUCTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 20: GLOBAL ARTERIOVENOUS FISTULA MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 21: GLOBAL ARTERIOVENOUS GRAFTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 22: GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 23: GLOBAL BLOODLINES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 24: HEMODIALYSIS CONCENTRATES/DIALYSATES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 25: GLOBAL OTHER HEMODIALYSIS CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 26: GLOBAL HEMODIALYSIS SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 27: GLOBAL HEMODIALYSIS SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 28: GLOBAL IN-CENTER HEMODIALYSIS SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 29: GLOBAL HOME HEMODIALYSIS SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 30: GLOBAL HEMODIALYSIS MARKET SIZE, BY MODALITY, 2014-2021 (USD BILLION)
  • TABLE 31: GLOBAL CONVENTIONAL LONG-TERM HEMODIALYSIS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 32: GLOBAL SHORT DAILY HEMODIALYSIS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 33: GLOBAL NOCTURNAL HEMODIALYSIS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 34: GLOBAL WATER TREATMENT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 35: GLOBAL WATER TREATMENT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: GLOBAL CENTRAL WATER DISINFECTION SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 37: GLOBAL CENTRAL WATER DISINFECTION SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: GLOBAL CENTRAL WATER CHEMICAL DISINFECTION SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: GLOBAL CENTRAL WATER HEAT DISINFECTION SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: GLOBAL CENTRAL WATER DISINFECTION SYSTEM ACCESSORIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: GLOBAL PORTABLE WATER DISINFECTION SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 42: GLOBAL PORTABLE WATER DISINFECTION SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: GLOBAL PORTABLE WATER CHEMICAL DISINFECTION SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 44: GLOBAL PORTABLE WATER HEAT DISINFECTION SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 45: GLOBAL PORTABLE WATER DISINFECTION SYSTEM ACCESSORIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 47: GLOBAL PERITONEAL DIALYSIS PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 48: GLOBAL PERITONEAL DIALYSIS PRODUCTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 49: GLOBAL PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 50: GLOBAL PERITONEAL DIALYSIS MACHINES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 51: GLOBAL PERITONEAL DIALYSIS CATHETERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 52: GLOBAL PERITONEAL DIALYSIS TRANSFER SETS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 53: GLOBAL OTHER PERITONEAL DIALYSIS PRODUCTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 54: GLOBAL PERITONEAL DIALYSIS SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 55: GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2014-2021 (USD BILLION)
  • TABLE 56: GLOBAL CAPD MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 57: GLOBAL APD MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 58: GLOBAL DIALYSIS END-USER MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 59: GLOBAL IN-CENTER DIALYSIS END-USER MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 60: GLOBAL IN-CENTER DIALYSIS END-USER MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 61: GLOBAL HOSPITAL DIALYSIS END-USER MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 62: GLOBAL INDEPENDENT DIALYSIS CENTERS END-USER MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 63: GLOBAL HOME DIALYSIS END-USER MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 64: GLOBAL HOME DIALYSIS END-USER MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 65: GLOBAL PERITONEAL DIALYSIS END-USER MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 66: GLOBAL HOME HEMODIALYSIS END-USER MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 67: GLOBAL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 68: NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 69: NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 70: NORTH AMERICA: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 71: NORTH AMERICA: HEMODIALYSIS MARKET SIZE, BY MODALITY, 2014-2021 (USD BILLION)
  • TABLE 72: NORTH AMERICA: WATER TREATMENT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: NORTH AMERICA: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 74: NORTH AMERICA: PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2014-2021 (USD BILLION)
  • TABLE 75: U.S.: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 76: U.S.: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 77: U.S.: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021(USD BILLION)
  • TABLE 78: CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 79: CANADA: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 80: CANADA: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 81: EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 82: EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 83: EUROPE: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 84: EUROPE: HEMODIALYSIS MARKET SIZE, BY MODALITY, 2014-2021 (USD BILLION)
  • TABLE 85: EUROPE: WATER TREATMENT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 86: EUROPE: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 87: EUROPE: PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2014-2021 (USD BILLION)
  • TABLE 88: GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 89: GERMANY: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 90: GERMANY: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 91: FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 92: FRANCE: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 93: FRANCE: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 94: U.K.: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 95: U.K.: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 96: U.K.: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 97: REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 98: REST OF EUROPE: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 99: REST OF EUROPE: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 100: ASIA-PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 101: ASIA-PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 102: ASIA-PACIFIC: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 103: ASIA-PACIFIC: HEMODIALYSIS MARKET SIZE, BY MODALITY, 2014-2021 (USD BILLION)
  • TABLE 104: ASIA-PACIFIC: WATER TREATMENT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 105: ASIA-PACIFIC: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 106: ASIA-PACIFIC: PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2014-2021 (USD BILLION)
  • TABLE 107: JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 108: JAPAN: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 109: JAPAN: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 110: CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 111: CHINA: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 112: CHINA: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 113: INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 114: INDIA: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 115: INDIA: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 116: ROAPAC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 117: ROAPAC: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 118: ROAPAC: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 119: ROW: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 120: ROW: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 121: ROW: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 122: ROW: HEMODIALYSIS MARKET SIZE, BY MODALITY, 2014-2021 (USD BILLION)
  • TABLE 123: ROW: WATER TREATMENT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 124: ROW: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 125: ROW: PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2014-2021 (USD BILLION)
  • TABLE 126: LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 127: LATIN AMERICA: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 128: LATIN AMERICA: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 129: MIDDLE EAST: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 130: MIDDLE EAST: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 131: MIDDLE EAST: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 132: AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 133: AFRICA: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD BILLION)
  • TABLE 134: AFRICA: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD BILLION)
  • TABLE 135: MARKET EXPANSIONS FOR PRODUCTS, 2013-2016
  • TABLE 136: MARKET EXPANSIONS FOR SERVICES, 2013-2016
  • TABLE 137: MERGERS & ACQUISITIONS, 2013-2016
  • TABLE 138: AGREEMENTS & PARTNERSHIPS, 2013-2016
  • TABLE 139: PRODUCT LAUNCHES AND APPROVALS, 2013-2016
  • TABLE 140: OTHER STRATEGIES, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL DIALYSIS MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: DATA TRIANGULATION METHODOLOGY
  • FIGURE 4: GLOBAL DIALYSIS MARKET, 2016-2021 (USD BILLION)
  • FIGURE 5: GLOBAL HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2016 VS. 2021
  • FIGURE 6: GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT, 2016 VS. 2021
  • FIGURE 7: GLOBAL DIALYSIS MARKET, BY REGION
  • FIGURE 8: EMERGING COUNTRIES OFFER HIGH-GROWTH OPPORTUNITIES TO PLAYERS IN THE DIALYSIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 9: INDIA AND CHINA ARE THE MOST LUCRATIVE MARKETS FOR HEMODIALYSIS & PERITONEAL DIALYSIS MARKET PLAYERS
  • FIGURE 10: HEMODIALYSIS PRODUCTS SEGMENT TO LEAD THE DIALYSIS MARKET ACROSS ALL REGIONS BY 2021
  • FIGURE 11: HOSPITAL DIALYSIS WILL CONTINUE TO DOMINATE THE MARKET TILL 2021
  • FIGURE 12: HEMODIALYSIS SEGMENT TO DOMINATE THE GLOBAL HEMODIALYSIS & PERITONEAL MARKET IN 2021
  • FIGURE 13: PERITONEAL DIALYSIS MACHINES SEGMENT TO GROW AT THE HIGHEST RATE DURING 2016-2021
  • FIGURE 14: HEMOHEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: NUMBER OF PATIENTS WITH RENAL DISORDERS, BY TREATMENT TYPES (2010 VS. 2015 VS. 2020)
  • FIGURE 16: DIABETES AND HYPERTENSION-KEY CAUSES FOR ESRD AND CKD
  • FIGURE 17: RATE OF COMPLICATIONS ASSOCIATED WITH VARIOUS TYPES OF DIALYSIS ACCESS PRODUCTS (2013)
  • FIGURE 18: EMERGING MARKETS REPRESENT AN UNDERSERVED PATIENT POPULATION
  • FIGURE 19: PORTER'S FIVE FORCES ANALYSIS: DIALYSIS MARKET
  • FIGURE 20: SCORING METHODOLOGY
  • FIGURE 21: COMPARISON OF COMPETITIVE INTENSITY SCORES: FRESENIUS, BAXTER, AND B.BRAUN
  • FIGURE 22: RELATIVE POSITIONING OF COMPANIES BASED ON COMPETITIVE INTENSITY SCORE AND DIALYSIS FOCUS
  • FIGURE 23: ORGANIC AND INORGANIC GROWTH STRATEGIES: DIALYSIS PRODUCTS VS. DIALYSIS SERVICES MARKETS (2013-2016)
  • FIGURE 24: ORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2013-2016)
  • FIGURE 25: INORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2013-2016)
  • FIGURE 26: ORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2013-2016)
  • FIGURE 27: INORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2013-2016)
  • FIGURE 28: REIMBURSEMENT SCENARIO OF DIALYSIS IN 2016
  • FIGURE 29: LEVEL OF REIMBURSEMENT FOR HD AND PD ACROSS EUROPE, 2016
  • FIGURE 30: DIALYSIS REIMBURSEMENT BASE ACROSS EUROPE AND MIDDLE EAST COUNTRIES 85  
  • FIGURE 31: EUROPE: VARIANCE IN REIMBURSEMENT STRUCTURES
  • FIGURE 32: DIALYSIS COVERAGE IN ASIA-PACIFIC COUNTRIES, 2015
  • FIGURE 33: REIMBURSEMENT DYNAMICS FOR DIALYSIS ACROSS ASIAN NATIONS
  • FIGURE 34: REIMBURSEMENT FOR HD AND PD ACROSS ASIA-PACIFIC COUNTRIES, 2015
  • FIGURE 35: KEY REGULATORY BODIES INVOLVED IN THE APPROVAL OF NEW DIALYSIS PRODUCTS
  • FIGURE 36: NUMBER OF DIALYSIS PATIENTS, BY REGION, 2015
  • FIGURE 37: IN-CENTER HEMODIALYSIS IS THE MOST WIDELY USED HD MODALITY FOR ESRD TREATMENT ACROSS THE GLOBE
  • FIGURE 38: CAPD WAS THE MOST WIDELY USED PD MODALITY AMONG ESRD PATIENTS IN 2013
  • FIGURE 39: HD PROCEDURES ARE PREFERRED OVER PD AMONG RENAL PATIENTS IN MOST COUNTRIES, 2013
  • FIGURE 40: WORLDWIDE UTILIZATION OF HD AND PD, BY REGION, 2015
  • FIGURE 41: HEMODIALYSIS SERVICES SEGMENT TO DOMINATE THE GLOBAL DIALYSIS MARKET IN 2016 VS 2021
  • FIGURE 42: CONVENTIONAL HEMODIALYSIS SEGMENT IS EXPECTED TO DOMINATE THE GLOBAL HEMODIALYSIS MARKET, BY MODALITY, IN 2016
  • FIGURE 43: GLOBAL PERITONEAL DIALYSIS MARKET SHARE, BY PRODUCT AND SERVICE, 2016 VS. 2021
  • FIGURE 44: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2016
  • FIGURE 45: HOME DIALYSIS SEGMENT EXPECTED TO HOLD GREATER SHARE OF THE MARKET BY 2021
  • FIGURE 46: GEOGRAPHIC SNAPSHOT (2016): ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 47: NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
  • FIGURE 48: PATIENT GROWTH: EUROPE (2012-2013)
  • FIGURE 49: EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
  • FIGURE 50: ASIA-PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
  • FIGURE 51: ROW: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
  • FIGURE 52: LEADING MARKET PLAYERS ADOPTED EXPANSION, MERGERS & ACQUISITIONS AS KEY GROWTH STRATEGIES DURING 2013-2016
  • FIGURE 53: FRESENIUS TO BE LEADER IN THE DIALYSIS MARKET DUE TO ITS LEADERSHIP IN ALL DIALYSIS SEGMENTS
  • FIGURE 54: GLOBAL HEMODDIALYSIS AND PERITONEAL DIALYSIS MARKET SHARE, BY KEY PLAYERS, 2015
  • FIGURE 55: GLOBAL HEMODIALYSIS PRODUCTS MARKET SHARE, BY KEY PLAYERS, 2015
  • FIGURE 56: TOP DIALYSIS SERVICES PROVIDERS, BY REGION, 2015
  • FIGURE 57: GLOBAL HEMODIALYSIS SERVICES MARKET SHARE, BY KEY PLAYERS, 2015
  • FIGURE 58: NUMBER OF DIALYSIS PATIENTS TREATED BY VARIOUS SERVICE PROVIDERS, BY REGION, 2015
  • FIGURE 59: KEY PLAYERS IN THE PERITONEAL DIALYSIS PRODUCTS MARKET 2015
  • FIGURE 60: GEOGRAPHIC REVENUE MIX OF TOP MARKET PLAYERS
  • FIGURE 61: FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2015)
  • FIGURE 62: DAVITA HEALTHCARE PARTNERS INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 63: BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 64: B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2015)
  • FIGURE 65: NIPRO CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 66: NXSTAGE MEDICAL, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 67: NIKKISO CO., LTD: COMPANY SNAPSHOT (2015)
  • FIGURE 68: CANTEL MEDICAL CORPORATION.: COMPANY SNAPSHOT (2016)
  • FIGURE 69: ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2015)
Back to Top